Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | Notes
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s)
‘005-006-00-7 | dibutyltin hydrogen borate | 401-040-5 | 75113-37-0 |
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360FD
H341
H372**
H312
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H360FD
H341
H372**
H312
H302
H318
H317
H410
005-007-00-2 |
boric acid; [1]
boric acid; [2]
233-139-2 [1]
234-343-4 [2]
10043-35-3 [1]
11113-50-1 [2]
Repr. 1B | H360FD |
GHS08
Dgr
H360FD | | Repr. 1B; H360FD: C ≥ 5,5 % |
005-017-00-7 |
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Ox. Sol. 2
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-017-01-4 |
sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
231-556-4 [2]
15120-21-5 [1]
7632-04-4 [2]
Ox. Sol. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-018-00-2 |
perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
239-172-9 [1]
234-390-0 [2]
231-556-4 [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. 1B
STOT SE 3
Eye Dam. 1
H360Df
H335
H318
GHS05
GHS08
GHS07
Dgr
H360Df
H335
H318
Repr. 1B; H360Df: C ≥ 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C ≥ 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-019-00-8 |
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Ox. Sol. 3
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H302
H335
H318
GHS03
GHS05
GHS08
GHS07
Dgr
H272
H360Df
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-019-01-5 |
perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate [3]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
234-390-0 [1]
234-390-0 [2]
231-556-4 [3]
11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]
Ox. Sol. 3
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1
H272
H360Df
H331
H302
H335
H318
GHS03
GHS06
GHS05
GHS08
Dgr
H272
H360Df
H331
H302
H335
H318
Repr. 1B; H360Df: C ≥ 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C ≥ 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %
006-015-00-9 |
diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4 | 330-54-1 |
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373**
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H373**
H410
M = 10 |
006-087-00-1 |
furathiocarb (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate
265-974-3 | 65907-30-4 |
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H301
H373**
H319
H315
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H301
H373**
H319
H315
H317
H410
M = 100 |
006-098-00-1 | tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate | 429-170-8 | 134575-17-0 |
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373**
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373**
H318
H317
007-007-00-8 | ethyl nitrate | 210-903-3 | 625-58-1 | Unst. Expl. | H200 |
GHS01
Dgr
H200 | | |
014-043-00-8 | reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) | 432-200-2 | — |
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H335
H315
H318
H412
GHS05
GHS07
Dgr
H335
H315
H318
H412
015-114-00-6 |
chlormephos (ISO);
S-chloromethyl O,O-diethyl phosphorodithioate
246-538-1 | 24934-91-6 |
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H400
H410
GHS06
GHS09
Dgr
H310
H300
H410
M = 10 |
015-115-00-1 |
chlorthiophos (ISO);
[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]
244-663-6 | 21923-23-9 |
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H311
H400
H410
GHS06
GHS09
Dgr
H300
H311
H410
M = 1000 |
015-182-00-7 | tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate) | 430-630-5 | 10596-22-2 |
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H302
H319
H317
GHS07
Wng
H302
H319
H317
016-092-00-0 |
reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol
427-050-1 | — |
Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f
H315
H317
H410
017-001-00-7 | chlorine | 231-959-5 | 7782-50-5 |
Ox. Gas 1
Press. Gas
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H270
H331
H319
H335
H315
H400
GHS03
GHS04
GHS06
GHS09
Dgr
H270
H331
H319
H335
H315
H400
M = 100 | U
017-012-00-7 | calcium hypochlorite | 231-908-7 | 7778-54-3 |
Ox. Sol. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
H272
H302
H314
H400
GHS03
GHS05
GHS07
GHS09
Dgr
H272
H302
H314
H400
EUH031 |
Skin Corr. 1B; H314: C ≥ 5 %
Skin Irrit. 2; H315: 1 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %
M = 10
T
022-004-00-1 | potassium titanium oxide (K2Ti6O13) | 432-240-0 | 12056-51-8 | Carc. 2 | H351 |
GHS08
Wng
H351 | | |
024-004-00-7 | sodium dichromate | 234-190-3 | 10588-01-9 |
Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H400
H410
GHS03
GHS06
GHS05
GHS08
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H410
Resp. Sens. 1; H334: C ≥ 0,2 %
Skin Sens. 1; H317: C ≥ 0,2 %
STOT SE 3; H335: C ≥ 5 %
3
027-006-00-6 | cobalt di(acetate) | 200-755-8 | 71-48-7 |
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M = 10
1
027-009-00-2 | cobalt dinitrate | 233-402-1 | 10141-05-6 |
Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F***
H334
H317
H410
Carc. 1B; H350i: C ≥ 0,01 %
M = 10
1
028-009-00-5 | nickel sulfate | 232-104-9 | 7786-81-4 |
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-011-00-6 | nickel dichloride | 231-743-0 | 7718-54-9 |
Carc. 1A
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-012-00-1 |
nickel dinitrate; [1]
nitric acid, nickel salt [2]
236-068-5 [1]
238-076-4 [2]
13138-45-9 [1]
14216-75-2 [2]
Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350i
H341
H360D***
H372**
H332
H302
H315
H318
H334
H317
H400
H410
GHS03
GHS05
GHS08
GHS07
GHS09
Dgr
H272
H350i
H341
H360D***
H372**
H332
H302
H315
H318
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C ≥ 20 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-022-00-6 |
nickel di(acetate); [1]
nickel acetate [2]
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C ≥ 0,01 %
M = 1
028-052-00-X |
nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900
271-853-6 | 68610-24-2 |
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372**
H317
GHS08
GHS07
Dgr
H350i
H372**
H317
050-008-00-3 | tributyltin compounds, with the exception of those specified elsewhere in this Annex | — | — |
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H372**
H319
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H312
H372**
H319
H315
H410
*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,25 % ≤ C < 1 %
Skin Irrit. 2; H315: C ≥ 1 %
Eye Irrit. 2; H319: C ≥ 1 %
M = 10
A
1
603-023-00-X |
ethylene oxide;
oxirane
200-849-9 | 75-21-8 |
Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H220
H350
H340
H331
H319
H335
H315
GHS02
GHS04
GHS06
GHS08
Dgr
H220
H350
H340
H331
H319
H335
H315
U
603-194-00-0 |
2-(2-aminoethylamino)ethanol;
(AEEA)
203-867-5 | 111-41-1 |
Repr. 1B
Skin Corr. 1B
Skin Sens. 1
H360Df
H314
H317
GHS05
GHS08
GHS07
Dgr
H360Df
H314
H317
STOT SE 3; H335: C ≥ 5 % |
604-030-00-0 |
bisphenol A;
4,4’-isopropylidenediphenol
201-245-8 | 80-05-7 |
Repr. 2
STOT SE 3
Eye Dam. 1
Skin Sens. 1
H361f***
H335
H318
H317
GHS05
GHS08
GHS07
Dgr
H361f***
H335
H318
H317
604-076-00-1 | phenolphthalein | 201-004-7 | 77-09-8 |
Carc. 1B
Muta. 2
Repr. 2
H350
H341
H361f***
GHS08
Dgr
H350
H341
H361f***
Carc. 1B; H350: C ≥ 1 % |
604-079-00-8 | 4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol | 428-970-4 | 13595-25-0 |
Repr. 2
Skin Sens. 1
Aquatic Chronic 2
H361f***
H317
H411
GHS08
GHS07
GHS09
Wng
H361f***
H317
H411
605-005-00-7 |
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde
203-600-2 | 108-62-3 |
Flam. Sol. 2
Acute Tox. 4 *
H228
H302
GHS02
GHS07
Wng
H228
H302
606-109-00-5 | 2-(4-methyl-3-pentenyl)anthraquinone | 428-320-1 | 71308-16-2 |
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4
H302
H317
H413
GHS07
Wng
H302
H317
H413
606-113-00-7 | 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one | 429-040-0 | 272460-97-6 |
Eye Dam. 1
Aquatic Chronic 4
H318
H413
GHS05
Dgr
H318
H413
607-177-00-9 |
tribenuron-methyl (ISO);
methyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate
401-190-1 | 101200-48-0 |
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
M = 100 |
607-245-00-8 | tert-butyl acrylate | 216-768-7 | 1663-39-4 |
Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H332
H312
H302
H335
H315
H317
H411
GHS02
GHS07
GHS09
Dgr
H225
H332
H312
H302
H335
H315
H317
H411
D
607-504-00-5 | diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate | 422-670-7 | — |
Repr. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H361f
H301
H373**
H400
H410
GHS06
GHS08
GHS09
Dgr
H361f
H301
H373**
H410
607-518-00-1 | 3-oxoandrost-4-ene-17-β-carboxylic acid | 414-990-0 | 302-97-6 |
Repr. 2
Aquatic Chronic 4
H361f
H413
GHS08
Wng
H361f
H413
607-547-00-X | 18-methylnonadecyl 2,2-dimethylpropanoate | 424-370-1 | 125496-22-2 |
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
607-550-00-6 | 2-amino-4-bromo-5-chlorobenzoic acid | 424-700-4 | — |
Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
607-591-00-X |
reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;
disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate
428-400-4 | — | Eye Dam. 1 | H318 |
GHS05
Dgr
H318 | | |
608-011-00-8 |
oxalonitrile;
cyanogen
207-306-5 | 460-19-5 |
Press. Gas
Flam. Gas 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H220
H331
H400
H410
GHS02
GHS04
GHS06
GHS09
Dgr
H220
H331
H410
U
608-057-00-9 | 4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate | 431-200-1 | 208538-34-5 |
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
609-072-00-3 | 4-mesyl-2-nitrotoluene | 430-550-0 | 1671-49-4 |
Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H361f***
H302
H317
H412
GHS08
GHS07
Wng
H361f***
H302
H317
H412
611-028-00-3 | C,C'-azodi(formamide) | 204-650-8 | 123-77-3 | Resp. Sens. 1 | H334 |
GHS08
Dgr
H334 | | | G
611-164-00-3 |
reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile;
2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile);
2,2’-dimethyl-2,2’-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile)
429-710-2 | — |
Self-react. D
Acute Tox. 4 *
Aquatic Chronic 2
H242
H302
H411
GHS02
GHS07
GHS09
Dgr
H242
H302
H411
612-237-00-2 |
hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]
233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]
10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]
Expl. 1.1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H312
H302
H373**
H319
H315
H317
H400
GHS01
GHS08
GHS07
GHS09
Dgr
H201
H351
H312
H302
H373**
H319
H315
H317
H400
T
613-010-00-0 |
ametryn (ISO);
N-ethyl-N'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine
212-634-7 | 834-12-8 |
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
M = 100 |
613-120-00-9 |
bioresmethrin (ISO);
(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate
249-014-0 | 28434-01-7 |
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 | | M = 1000 |
613-139-00-2 |
metsulfuron-methyl (ISO);
methyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate
| 74223-64-6 |
Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410 | | M = 1000 |
613-161-00-2 | (2,4-diaminopteridin-6-yl)methanol hydrobromide | 430-620-0 | 76145-91-0 |
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H373**
H317
H412
GHS08
GHS07
Wng
H373**
H317
H412
613-204-00-5 |
oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
254-637-6 | 39807-15-3 |
Repr. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H361d***
H373**
H400
H410
GHS08
GHS09
Wng
H361d***
H373**
H410
M = 1000 |
613-275-00-2 | 3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride | 424-530-0 | 93076-03-0 |
Acute Tox. 3 *
STOT SE 2
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H301
H371**
H373**
H318
H317
H411
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H371**
H373**
H318
H317
H411
616-157-00-9 | 3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride | 427-780-9 | 114565-70-7 |
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
617-008-00-0 |
dibenzoyl peroxide;
benzoyl peroxide
202-327-6 | 94-36-0 |
Org. Perox. B
Eye Irrit. 2
Skin Sens. 1
H241
H319
H317
GHS01
GHS02
GHS07
Dgr
H241
H319
H317
617-010-00-1 |
1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1’-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]
78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]
Org. Perox. A
Skin Corr. 1B
Acute Tox. 4 *
H240
H314
H302
GHS01
GHS05
GHS07
Dgr
H240
H314
H302
STOT SE 3; H335: C ≥ 5 % | C
649-062-00-6 |
Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;
Petroleum gas;
[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]
270-755-0 | 68477-73-6 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-063-00-1 |
Gases (petroleum), catalytic cracker;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-756-6 | 68477-74-7 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-064-00-7 |
Gases (petroleum), catalytic cracker, C1-5-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]
270-757-1 | 68477-75-8 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-065-00-2 |
Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]
270-758-7 | 68477-76-9 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-066-00-8 |
Gases (petroleum), catalytic reformer, C1-4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]
270-760-8 | 68477-79-2 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-067-00-3 |
Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;
Petroleum gas;
[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]
270-765-5 | 68477-83-8 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-068-00-9 |
Gases (petroleum), C4-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-767-6 | 68477-85-0 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-069-00-4 |
Gases (petroleum), deethanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]
270-768-1 | 68477-86-1 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-070-00-X |
Gases (petroleum), deisobutanizer tower overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-769-7 | 68477-87-2 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-071-00-5 |
Gases (petroleum), depropanizer dry, propene-rich;
Petroleum gas;
[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]
270-772-3 | 68477-90-7 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-072-00-0 |
Gases (petroleum), depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-773-9 | 68477-91-8 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-073-00-6 |
Gases (petroleum), gas recovery plant depropanizer overheads;
Petroleum gas;
[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]
270-777-0 | 68477-94-1 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-074-00-1 |
Gases (petroleum), Girbotol unit feed;
Petroleum gas;
[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-778-6 | 68477-95-2 |
Press. Gas
Flam. Gas 1
Carc. 1A
Muta. 1B
H220
H350
H340
GHS04
GHS02
GHS08
Dgr
H220
H350
H340
K U
649-075-00-7 |
Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;
Petroleum gas
270-782-8 | 68477-99-6 |
Press. Gas